A048410 logo

Hyundai Bioscience Co., Ltd. Stock Price

KOSDAQ:A048410 Community·₩476.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A048410 Share Price Performance

₩4,965.00
-2235.00 (-31.04%)
₩4,965.00
-2235.00 (-31.04%)
Price ₩4,965.00

A048410 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Hyundai Bioscience Co., Ltd. Key Details

₩2.0b

Revenue

₩1.9b

Cost of Revenue

₩81.3m

Gross Profit

₩22.0b

Other Expenses

-₩22.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-228.71
4.15%
-1,120.49%
2.6%
View Full Analysis

About A048410

Founded
2000
Employees
54
CEO
Jong-Won Choi
WebsiteView website
www.hyundaibioscience.com

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.

Recent A048410 News & Updates

Does Hyundai Bioscience (KOSDAQ:048410) Have A Healthy Balance Sheet?

Aug 19
Does Hyundai Bioscience (KOSDAQ:048410) Have A Healthy Balance Sheet?

Recent updates

No updates

Hyundai Bioscience Co., Ltd. Competitors